Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
ClinicalTrials.gov study NCT00697671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery
ClinicalTrials.gov study NCT02326727. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
ClinicalTrials.gov study NCT00569283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
ClinicalTrials.gov study NCT03300492. IPD Sharing: NO. Countries: 1. Publications: 0.
Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19
ClinicalTrials.gov study NCT04900454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
ClinicalTrials.gov study NCT03902912. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment
ClinicalTrials.gov study NCT02370017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma
ClinicalTrials.gov study NCT07144384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML
ClinicalTrials.gov study NCT07026942. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05665075. IPD Sharing: NO. Countries: 1. Publications: 0.
Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects
ClinicalTrials.gov study NCT06015256. IPD Sharing: NO. Countries: 1. Publications: 0.
Novel Blood-based Colorectal Cancer Screening Method Using Natural Killer Cell Activity and Gene Panel Expression
ClinicalTrials.gov study NCT03289988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Enhanced Natural Killer Cell Activity and RBAC
ClinicalTrials.gov study NCT02019628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD
ClinicalTrials.gov study NCT06568328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML
ClinicalTrials.gov study NCT05272293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer
ClinicalTrials.gov study NCT00823524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
ClinicalTrials.gov study NCT05990920. IPD Sharing: NO. Countries: 1. Publications: 0.
VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)
ClinicalTrials.gov study NCT02544425. IPD Sharing: YES. Countries: 1. Publications: 0.
Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab
ClinicalTrials.gov study NCT02845999. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor
ClinicalTrials.gov study NCT01212341. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.